FI930553A0 - Foerfaranden foer att foerhindra eller minska vaevnadsskador med nya antioxidanter eller spolmedel med fria radikaler - Google Patents

Foerfaranden foer att foerhindra eller minska vaevnadsskador med nya antioxidanter eller spolmedel med fria radikaler

Info

Publication number
FI930553A0
FI930553A0 FI930553A FI930553A FI930553A0 FI 930553 A0 FI930553 A0 FI 930553A0 FI 930553 A FI930553 A FI 930553A FI 930553 A FI930553 A FI 930553A FI 930553 A0 FI930553 A0 FI 930553A0
Authority
FI
Finland
Prior art keywords
eller
med
vaevnadsskador
spolmedel
radikaler
Prior art date
Application number
FI930553A
Other languages
English (en)
Other versions
FI930553A (fi
Inventor
Ernest K Metzner
Harry E Gruber
David A Bullough
Kevin M Mullane
Bheemarao G Ugarkar
Clinton E Browne
Original Assignee
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Pharma filed Critical Gensia Pharma
Publication of FI930553A0 publication Critical patent/FI930553A0/fi
Publication of FI930553A publication Critical patent/FI930553A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FI930553A 1990-08-10 1993-02-09 Foerfaranden foer att foerhindra eller minska vaevnadsskador med nya antioxidanter eller spolmedel med fria radikaler FI930553A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56619790A 1990-08-10 1990-08-10
US73218191A 1991-07-17 1991-07-17
PCT/US1991/005695 WO1992002213A1 (en) 1990-08-10 1991-08-09 Methods of preventing or decreasing tissue damage by novel antioxidants and free radical scavengers

Publications (2)

Publication Number Publication Date
FI930553A0 true FI930553A0 (fi) 1993-02-09
FI930553A FI930553A (fi) 1993-03-24

Family

ID=27074103

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930553A FI930553A (fi) 1990-08-10 1993-02-09 Foerfaranden foer att foerhindra eller minska vaevnadsskador med nya antioxidanter eller spolmedel med fria radikaler

Country Status (9)

Country Link
EP (1) EP0542867A4 (fi)
JP (1) JPH06500101A (fi)
AU (1) AU651131B2 (fi)
CA (1) CA2089145A1 (fi)
FI (1) FI930553A (fi)
IE (1) IE912834A1 (fi)
IL (1) IL99125A0 (fi)
MX (1) MX9100603A (fi)
WO (1) WO1992002213A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103294A0 (en) * 1991-09-30 1993-05-13 Gensia Pharma Pharmaceutical compositions for preventing tissue damage associated with decreased blood flow
CA2477795A1 (en) * 2002-02-28 2003-09-12 Kandasamy Sakthivel Nucleoside 5'-monophosphate mimics and their prodrugs
JP2008534601A (ja) * 2005-03-28 2008-08-28 ペリコー セラピューティクス， インコーポレイテッド 患者における副作用を予防または減少するための方法、組成物および処方物
US8461192B2 (en) 2007-09-13 2013-06-11 The University Of South Florida Method of selectively inhibiting PKCiota
WO2010040110A1 (en) 2008-10-03 2010-04-08 Pericor Therapeutics, Inc. Methods and compositions for treatment of acute heart failure
US9073960B2 (en) 2011-12-22 2015-07-07 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT350735B (de) * 1976-08-06 1979-06-11 Hoffmann La Roche Verfahren zur herstellung von neuen ribo- furanosyl-imidazolderivaten
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
US5132291A (en) * 1989-01-24 1992-07-21 Gensia Pharmaceuticals, Inc. Antivirals and methods for increasing the antiviral activity of azt

Also Published As

Publication number Publication date
IL99125A0 (en) 1992-07-15
EP0542867A1 (en) 1993-05-26
FI930553A (fi) 1993-03-24
IE912834A1 (en) 1992-02-12
CA2089145A1 (en) 1992-02-11
EP0542867A4 (en) 1993-07-28
JPH06500101A (ja) 1994-01-06
AU651131B2 (en) 1994-07-14
MX9100603A (es) 1992-04-01
WO1992002213A1 (en) 1992-02-20
AU8406291A (en) 1992-03-02

Similar Documents

Publication Publication Date Title
FI930381A (fi) Nya vaermestabila pullulanaser
FI924672A (fi) Nya antimikrobiella kinolontioureas
FI924557A (fi) Nya fenylpyrazolfungicider
FI931843A0 (fi) Foerfarande foer agglomerering av aluminosilikat eller skiktade silikatverkningsmedel i tvaettmedel
FI924077A (fi) Nya omaettade acykliska purin- och pyrimidinfosfonatderivat
FI883659A0 (fi) Fria fettsyror avsedda foer vaord eller profylax av reumatisk ledinflammation.
FI921135A (fi) Nya karbonsyraamider
FI933451A0 (fi) Nya steroidestrar
FI933450A (fi) Nya steroider
FI925086A0 (fi) Nya hybrid-vaextfaktorer
FI921614A (fi) Nya herbicider
FI925548A0 (fi) Upprullningsanordning foer rullskaermaskiner av stoedvalstyp eller dylika
FI923872A (fi) Nya bensopyranderivat
FI932928A (fi) Nya bensodiazepinderivat
FI930553A (fi) Foerfaranden foer att foerhindra eller minska vaevnadsskador med nya antioxidanter eller spolmedel med fria radikaler
FI922552A (fi) Nya kefemfoereningar
FI910981A0 (fi) Tvaomodulisk amfibiomotorfordon med tvao eller flere axlar.
FI933157A0 (fi) Foerbaettringar i beklaednad av roerledningar eller kanaler
FI924883A0 (fi) Nya alkaloider och foerfaranden foer produktion daerav
FI925722A (fi) Nya tiazoler
FI925679A (fi) Nya imidazoler
FI922425A (fi) Nya 14-kron-4-eterderivat
FI922855A (fi) Laett foerslutningsbar paose eller saeck
FI923674A (fi) Nya herbicider
FI934558A0 (fi) Lastnings- och/eller lossningsanordning foer faerja

Legal Events

Date Code Title Description
FD Application lapsed